ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death

Cell Death and Differentiation

Volumn 14, Issue 5, 2007, Pages 1040-1049

  Schulte, M ^a   Reiss, K ^a   Lettau, M ^b   Maretzky, T ^a   Ludwig, A ^a   Hartmann, D ^c   de Strooper, B ^c   Janssen, O ^b   Saftig, P ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Center for Human Genetics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM10 PROTEIN; DISINTEGRIN; FAS LIGAND; METALLOPROTEINASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; T LYMPHOCYTE; WESTERN BLOTTING;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CELL DEATH; ENZYME INHIBITORS; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; MEMBRANE PROTEINS; MICE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; SOLUBILITY; T-LYMPHOCYTES;

MURINAE;

EID: 34247382029     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402101     Document Type: Article

References (41)

1. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
2. Janssen O, Qian J, Linkermann A, Kabelitz D. CD95 ligand - death factor and costimulatory molecule? Cell Death Differ 2003; 10: 1215-1225.
3. Adam-Klages S, Adam D, Janssen O, Kabelitz D. Death receptors and caspases: Role in lymphocyte proliferation, cell death, and autoimmunity. Immunol Res 2005; 33: 149-166.
4. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154: 3806-3813.
5. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994; 370: 650-652.
6. Ethell DW, Kinloch R, Green DR. Metalloproteinase shedding of Fas ligand regulates beta-amyloid neurotoxicity. Curr Biol 2002; 12: 1595-1600.
7. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995; 182: 1777-1783.
8. Tanaka M, Itai T, Adachi M, Nagata S. Downregulation of Fas ligand by shedding. Nat Med 1998; 4: 31-36.
9. Mitsiades N, Yu WH, Poulaki V, Tsokos M, Stamenkovic I. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res 2001; 61 577-581.
10. Chen JJ, Sun Y, Nabel GJ. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 1998; 282: 1714-1717.
11. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A et al Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998; 187: 1205-1213.
12. Holler N, Tardivel A, Kovacsovics-Bankowski M, Hertig S, Gaide O, Martinon F et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol 2003; 23: 1428-1440.
13. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F et al. Fas ligand in human serum. Nat Med 1996; 2: 317-322.
14. Linkermann A, Qian J, Lettau M, Kabelitz D, Janssen O. Considering Fas ligand as a target for therapy. Expert Opin Ther Targets 2005; 9: 119-134.
15. Vargo-Gogola T, Crawford HC, Fingleton B, Matrisian LM. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys 2002; 408: 155-161.
16. Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 1999; 9: 1441-1447.
17. Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 2003; 17: 7-30.
18. Reiss K, Ludwig A, Saftig P. Breaking up the tie: Disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion. Pharmacol Ther 2006; 111: 985-1006.
19. Blobel CP. ADAMs: Key components in EGFR signalling and development. Nat Rev Mol Cell Biol 2005; 6: 32-43.
20. Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W et al. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet 2002; 11: 2615-2624.
21. Reiss K, Maretzky T, Ludwig A, Tousseyn T, de Strooper B, Hartmann D et al. ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J 2005; 24 742-752.
22. Alonso R, Rodriguez MC, Pindado J, Merino E, Merida I, Izquierdo M. Diacylglycerol kinase alpha regulates the secretion of lethal exosomes bearing Fas ligand during activation-induced cell death of T lymphocytes. J Biol Chem 2005; 280: 28439-28450.
23. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 2003; 102: 1186-1195.
24. Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E et al ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci USA 2005; 102: 9182-9187.
25. Schneider P, Bodmer JL, Holler N, Mattmann C, Scuderi P, Terskikh A et al. Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. J Biol Chem 1997; 272: 18827-18833.
26. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 1995; 14: 1129-1135.
27. Lettau M, Qian J, Kabelitz D, Janssen O. Activation dependent FasLigand expression in T lymphocytes and Natural Killer cells. Signal Transduction 2004; 5: 206-211.
28. Lettau M, Qian J, Linkermann A, Latreille M, Larose L, Kabelitz D et al. The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse. Proc Natl Acad Sci USA 2006; 103: 5911-5916.
29. Budd RC. Death receptors couple to both cell proliferation and apoptosis. J Clin Invest 2002; 109: 437-441.
30. Wesselborg S, Janssen O, Kabelitz D. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 1993; 150: 4338-4345.
31. Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev 2003; 193: 70-81.
32. Ferguson TA, Green DR, Griffith TS. Cell death and immune privilege. Int Rev Immunol 2002; 21: 153-172.
33. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: Genetic defects of apoptosis pathways. Cell Death Differ 2003; 10: 124-133.
34. Knox PG, Milner AE, Green NK, Eliopoulos AG, Young LS. Inhibition of metallo-proteinase cleavage enhances the cytotoxicity of Fas ligand. J Immunol 2003; 170: 677-685.
35. Matsuno H, Yudoh K, Watanabe Y, Nakazawa F, Aono H, Kimura T. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membranebound Fas ligand. J Rheumatol 2001; 28: 22-28.
36. Itai T, Tanaka M, Nagata S. Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form. Eur J Biochem 2001; 268: 2074-2082.
37. Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P, Iwatsubo T et al. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 2004; 165: 893-902.
38. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J et al Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004; 164: 769-779.
39. Maretzky T, Schulte M, Ludwig A, Rose-John S, Blobel C, Hartmann D et al. L1 is sequentially processed by two differently activated metalloproteases and Presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol Cell Biol 2005; 25: 9040-9053.
40. Sun M, Ames KT, Suzuki, Fink PJ. The cytoplasmic domain of Fas ligand costimulates TCR signals. J Immunol 2006; 177: 1481-1491.
41. Igney FH, Krammer PH. Tumor counterattack: Fact or fiction? Cancer Immunol Immunother 2005; 54: 1127-1136.